InvestorsHub Logo

Doc logic

02/13/19 3:40 PM

#214370 RE: exwannabe #214165

exwannabe,

Thanks for the clarification. Looks like sentiment_stocks nailed it and that no improvements were made. The only comparisons that make any sense to do now is to compare historical methylated and unmethylated responses from SOC to the results from this trial and adjust for trial inclusion and exclusion criteria. The data gives steady rates throughout the trial for methylated and unmethylated MGMT patients based on sentiment_stocks ability to project so let's have at it. Let's find an acceptable criteria adjusted historical SOC range and compare.
Best wishes.